Depreciation of ABVC BIOPHARMA, INC. from 31 Mar 2018 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
ABVC BIOPHARMA, INC. quarterly and annual Depreciation in USD history and change rate from 31 Mar 2018 to 31 Dec 2025.
  • ABVC BIOPHARMA, INC. Depreciation for the quarter ending 31 Dec 2025 was $13,718, a 23% decline year-over-year.
  • ABVC BIOPHARMA, INC. Depreciation for the twelve months ending 31 Dec 2025 was $25,330, a 21% decline year-over-year.
  • ABVC BIOPHARMA, INC. annual Depreciation for 2025 was $25,330, a 21% decline from 2024.
  • ABVC BIOPHARMA, INC. annual Depreciation for 2024 was $32,025, a 12% increase from 2023.
  • ABVC BIOPHARMA, INC. annual Depreciation for 2023 was $28,531, a 20% increase from 2022.
Source SEC data
View on sec.gov
Depreciation, Trailing 12 Months (USD)
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Change (%)
Depreciation, Annual (USD)
Depreciation, YoY Annual Change (%)

ABVC BIOPHARMA, INC. Quarterly Depreciation (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q4 2025 $25,330 $13,718 -$2,525 -23% 01 Oct 2025 31 Dec 2025 10-K 03 Mar 2026 2025 FY
Q3 2025 $27,855 $25,330 -$3,297 -12% 01 Jul 2025 30 Sep 2025 10-K 03 Mar 2026 2025 FY
Q2 2025 $31,152 $6,697 -$6,608 -50% 01 Apr 2025 30 Jun 2025 10-Q 13 Aug 2025 2025 Q2
Q1 2025 $37,760 $7,021 +$5,735 +446% 01 Jan 2025 31 Mar 2025 10-Q 30 Apr 2025 2025 Q1
Q4 2024 $32,025 $11,193 -$18,775 -248% 01 Oct 2024 31 Dec 2024 10-K 03 Mar 2026 2025 FY
Q3 2024 $50,800 $28,627 +$21,168 +284% 01 Jul 2024 30 Sep 2024 10-K 03 Mar 2026 2025 FY
Q2 2024 $29,632 $13,305 +$6,308 +90% 01 Apr 2024 30 Jun 2024 10-Q 13 Aug 2025 2025 Q2
Q1 2024 $23,324 $1,286 -$5,207 -80% 01 Jan 2024 31 Mar 2024 10-Q 30 Apr 2025 2025 Q1
Q4 2023 $28,531 $7,582 01 Oct 2023 31 Dec 2023 10-K 15 Apr 2025 2024 FY
Q3 2023 $7,459 01 Jul 2023 30 Sep 2023 10-Q 14 Nov 2024 2024 Q3
Q2 2023 $6,997 01 Apr 2023 30 Jun 2023 10-Q 14 Aug 2024 2024 Q2
Q1 2023 $6,493 +$1,082 +20% 01 Jan 2023 31 Mar 2023 10-Q 17 May 2024 2024 Q1
Q1 2022 $5,411 +$2,483 +85% 01 Jan 2022 31 Mar 2022 10-Q 15 May 2023 2023 Q1
Q2 2021 $21,412 $2,941 -$7,484 -72% 01 Apr 2021 30 Jun 2021 10-Q 12 Aug 2021 2021 Q2
Q1 2021 $28,896 $2,928 -$8,246 -74% 01 Jan 2021 31 Mar 2021 10-Q 16 May 2022 2022 Q1
Q4 2020 $37,142 $6,813 -$4,380 -39% 01 Oct 2020 31 Dec 2020 10-K 31 Mar 2022 2021 FY
Q3 2020 $41,522 $8,730 -$5,532 -39% 01 Jul 2020 30 Sep 2020 10-Q 17 Nov 2020 2020 Q3
Q2 2020 $47,054 $10,425 -$5,266 -34% 01 Apr 2020 30 Jun 2020 10-Q 12 Aug 2021 2021 Q2
Q1 2020 $52,320 $11,174 -$2,766 -20% 01 Jan 2020 31 Mar 2020 10-Q 10 May 2021 2021 Q1
Q4 2019 $55,086 $11,193 +$823 +7.9% 01 Oct 2019 31 Dec 2019 10-K 16 Mar 2021 2020 FY
Q3 2019 $54,263 $14,262 +$3,693 +35% 01 Jul 2019 30 Sep 2019 10-Q 17 Nov 2020 2020 Q3
Q2 2019 $50,570 $15,691 +$4,440 +39% 01 Apr 2019 30 Jun 2019 10-Q 14 Aug 2020 2020 Q2
Q1 2019 $46,130 $13,940 +$2,520 +22% 01 Jan 2019 31 Mar 2019 10-Q 29 Jun 2020 2020 Q1
Q4 2018 $43,610 $10,370 01 Oct 2018 31 Dec 2018 10-K 15 May 2020 2019 FY
Q3 2018 $10,569 01 Jul 2018 30 Sep 2018 10-Q 18 Nov 2019 2019 Q3
Q2 2018 $11,251 01 Apr 2018 30 Jun 2018 10-Q 09 Aug 2019 2019 Q2
Q1 2018 $11,420 01 Jan 2018 31 Mar 2018 10-Q 28 May 2019 2019 Q1

ABVC BIOPHARMA, INC. Annual Depreciation (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2025 $25,330 -$6,695 -21% 01 Jan 2025 31 Dec 2025 10-K 03 Mar 2026 2025 FY
2024 $32,025 +$3,494 +12% 01 Jan 2024 31 Dec 2024 10-K 03 Mar 2026 2025 FY
2023 $28,531 +$4,732 +20% 01 Jan 2023 31 Dec 2023 10-K 15 Apr 2025 2024 FY
2022 $23,799 +$11,806 +98% 01 Jan 2022 31 Dec 2022 10-K 13 Mar 2024 2023 FY
2021 $11,993 -$25,149 -68% 01 Jan 2021 31 Dec 2021 10-K 31 Mar 2023 2022 FY
2020 $37,142 -$17,944 -33% 01 Jan 2020 31 Dec 2020 10-K 31 Mar 2022 2021 FY
2019 $55,086 +$11,476 +26% 01 Jan 2019 31 Dec 2019 10-K 16 Mar 2021 2020 FY
2018 $43,610 01 Jan 2018 31 Dec 2018 10-K 15 May 2020 2019 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.